Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 10 of 407

Publication Record

Connections

Microvascular disease confers additional risk to COVID-19 infection.
Bale BF, Doneen AL, Vigerust DJ
(2020) Med Hypotheses 144: 109999
MeSH Terms: Adult, Aging, COVID-19, Cardiovascular Diseases, Child, Diabetes Mellitus, Disease Susceptibility, Humans, Hydrogen Peroxide, Hypertension, Hypochlorous Acid, Immunity, Innate, Lung, Microcirculation, Microvessels, Neutrophils, Pandemics, Peroxidase, Risk Factors, United States
Added June 25, 2020
0 Communities
1 Members
0 Resources
20 MeSH Terms
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society.
Lyon AR, Dent S, Stanway S, Earl H, Brezden-Masley C, Cohen-Solal A, Tocchetti CG, Moslehi JJ, Groarke JD, Bergler-Klein J, Khoo V, Tan LL, Anker MS, von Haehling S, Maack C, Pudil R, Barac A, Thavendiranathan P, Ky B, Neilan TG, Belenkov Y, Rosen SD, Iakobishvili Z, Sverdlov AL, Hajjar LA, Macedo AVS, Manisty C, Ciardiello F, Farmakis D, de Boer RA, Skouri H, Suter TM, Cardinale D, Witteles RM, Fradley MG, Herrmann J, Cornell RF, Wechelaker A, Mauro MJ, Milojkovic D, de Lavallade H, Ruschitzka F, Coats AJS, Seferovic PM, Chioncel O, Thum T, Bauersachs J, Andres MS, Wright DJ, López-Fernández T, Plummer C, Lenihan D
(2020) Eur J Heart Fail 22: 1945-1960
MeSH Terms: Aged, Androgen Antagonists, Antineoplastic Agents, Cardiovascular Diseases, Female, Heart Disease Risk Factors, Humans, Male, Middle Aged, Neoplasms, Risk Assessment, Risk Factors
Added May 29, 2020
0 Communities
1 Members
0 Resources
12 MeSH Terms
Cardiac Events Associated With Chimeric Antigen Receptor T-Cells (CAR-T): A VigiBase Perspective.
Salem JE, Ederhy S, Lebrun-Vignes B, Moslehi JJ
(2020) J Am Coll Cardiol 75: 2521-2523
MeSH Terms: Adult, Cardiovascular Diseases, Humans, Receptors, Chimeric Antigen, T-Lymphocytes
Added May 29, 2020
0 Communities
1 Members
0 Resources
5 MeSH Terms
Understanding the use of observational and randomized data in cardiovascular medicine.
Bowman L, Baras A, Bombien R, Califf RM, Chen Z, Gale CP, Gaziano JM, Grobbee DE, Maggioni AP, Muse ED, Roden DM, Schroeder S, Wallentin L, Casadei B
(2020) Eur Heart J 41: 2571-2578
MeSH Terms: Cardiology, Cardiovascular Diseases, Electronic Health Records, Europe, Humans, Registries
Added March 24, 2020
0 Communities
1 Members
0 Resources
6 MeSH Terms
Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer: Contemporary Meta-Analyses.
Hu JR, Duncan MS, Morgans AK, Brown JD, Meijers WC, Freiberg MS, Salem JE, Beckman JA, Moslehi JJ
(2020) Arterioscler Thromb Vasc Biol 40: e55-e64
MeSH Terms: Androgen Antagonists, Antineoplastic Agents, Hormonal, Cardiotoxicity, Cardiovascular Diseases, Cardiovascular System, Humans, Male, Prostatic Neoplasms, Risk Assessment, Risk Factors, Treatment Outcome
Added May 29, 2020
0 Communities
2 Members
0 Resources
11 MeSH Terms
Reverse Cardio-Oncology: Cancer Development in Patients With Cardiovascular Disease.
Aboumsallem JP, Moslehi J, de Boer RA
(2020) J Am Heart Assoc 9: e013754
MeSH Terms: Cardiology, Cardiovascular Diseases, Humans, Incidence, Inflammation, Inflammation Mediators, Medical Oncology, Neoplasms, Prevalence, Prognosis, Risk Assessment, Risk Factors, Signal Transduction, Specialization, Tumor Hypoxia, Tumor Microenvironment
Added May 29, 2020
0 Communities
1 Members
0 Resources
16 MeSH Terms
Cardio-Immuno-Oncology.
Zaha VG, Meijers WC, Moslehi J
(2020) Circulation 141: 87-89
MeSH Terms: Cardiovascular Diseases, Cell- and Tissue-Based Therapy, Cytokines, Humans, Immune System, Immunotherapy, Neoplasms, Prognosis
Added January 15, 2020
0 Communities
1 Members
0 Resources
8 MeSH Terms
Tyrosine Kinase Inhibitors in Leukemia and Cardiovascular Events: From Mechanism to Patient Care.
Manouchehri A, Kanu E, Mauro MJ, Aday AW, Lindner JR, Moslehi J
(2020) Arterioscler Thromb Vasc Biol 40: 301-308
MeSH Terms: Cardiovascular Diseases, Humans, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Patient Care, Protein Kinase Inhibitors, Protein-Tyrosine Kinases
Added January 15, 2020
0 Communities
1 Members
0 Resources
6 MeSH Terms
Cancer Treatment-Associated Pericardial Disease: Epidemiology, Clinical Presentation, Diagnosis, and Management.
Ala CK, Klein AL, Moslehi JJ
(2019) Curr Cardiol Rep 21: 156
MeSH Terms: Antineoplastic Agents, Immunological, Cardiotoxicity, Cardiovascular Diseases, Humans, Immunotherapy, Neoplasms, Pericarditis, Pericardium, Risk Factors
Added January 15, 2020
0 Communities
1 Members
0 Resources
9 MeSH Terms
Mechanisms and clinical course of cardiovascular toxicity of cancer treatment I. Oncology.
Yeh ETH, Ewer MS, Moslehi J, Dlugosz-Danecka M, Banchs J, Chang HM, Minotti G
(2019) Semin Oncol 46: 397-402
MeSH Terms: Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Cardiotoxicity, Cardiovascular Diseases, DNA Topoisomerases, Type II, Humans, Medical Oncology, Molecular Targeted Therapy, Neoplasms, Poly-ADP-Ribose Binding Proteins
Added January 15, 2020
0 Communities
1 Members
0 Resources
10 MeSH Terms